Total Payments
$744.47
2024 Payments
$362.76
Companies
15
Transactions
34
Medicare Patients
11,266
Medicare Billing
$821,240
Payment Breakdown by Category
Food & Beverage$744.47 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $744.47 | 34 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $152.58 | 4 | $0 (2024) |
| Boston Scientific Corporation | $112.02 | 1 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $67.78 | 5 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $60.47 | 4 | $0 (2018) |
| PFIZER INC. | $50.00 | 3 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $49.94 | 3 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $47.17 | 3 | $0 (2024) |
| GlaxoSmithKline, LLC. | $44.55 | 2 | $0 (2024) |
| LANTHEUS MEDICAL IMAGING, INC. | $38.02 | 1 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $34.49 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $362.76 | 9 | Boston Scientific Corporation ($112.02) |
| 2023 | $126.97 | 7 | PFIZER INC. ($34.57) |
| 2019 | $23.53 | 2 | Janssen Pharmaceuticals, Inc ($11.87) |
| 2018 | $43.24 | 3 | PFIZER INC. ($15.43) |
| 2017 | $187.97 | 13 | Sunovion Pharmaceuticals Inc. ($46.27) |
All Payment Transactions
34 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $21.77 | General |
| Category: Cardiovascular | ||||||
| 10/29/2024 | Boston Scientific Corporation | VersaCross Access Solution (Device) | Food and Beverage | In-kind items and services | $112.02 | General |
| Category: VersaCross Access Solution_ICG | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: Respiratory | ||||||
| 10/26/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $84.71 | General |
| Category: Cardiology | ||||||
| 08/15/2024 | LANTHEUS MEDICAL IMAGING, INC. | DEFINITY (Drug) | Food and Beverage | In-kind items and services | $38.02 | General |
| Category: CONTRAST AGENT | ||||||
| 05/13/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: EPILEPSY | ||||||
| 05/10/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: Inflammation | ||||||
| 04/29/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.99 | General |
| Category: RESPIRATORY | ||||||
| 03/21/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: PSYCHIATRY | ||||||
| 11/13/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: VACCINES | ||||||
| 09/27/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/11/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $25.59 | General |
| Category: Inflammation | ||||||
| 09/11/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/08/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: PSYCHIATRY | ||||||
| 08/22/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/29/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/22/2019 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $11.66 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/04/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $11.87 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/16/2018 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: Respiratory | ||||||
| 03/12/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 03/07/2018 | Braintree Laboratories, Inc. | SUPREP (Drug) | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/24/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/01/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/18/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), GLYXAMBI, TRADJENTA | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: DIABETES | ||||||
| 05/02/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.36 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 45 | 2,930 | 7,614 | $828,090 | $219,602 |
| 2022 | 40 | 2,723 | 5,678 | $735,410 | $212,379 |
| 2021 | 47 | 2,773 | 6,092 | $780,862 | $190,271 |
| 2020 | 44 | 2,840 | 5,336 | $783,451 | $198,988 |
Total Patients
11,266
Total Services
24,720
Medicare Billing
$821,240
Procedure Codes
176
All Medicare Procedures & Services
176 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 378 | 584 | $182,208 | $45,319 | 24.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 296 | 296 | $79,920 | $37,391 | 46.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 244 | 365 | $80,300 | $20,554 | 25.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 409 | 422 | $116,359 | $20,039 | 17.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 113 | 115 | $50,485 | $13,938 | 27.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 160 | 169 | $14,196 | $12,088 | 85.2% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 58 | 58 | $65,772 | $11,522 | 17.5% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 48 | 371 | $20,776 | $5,877 | 28.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 182 | 193 | $7,190 | $5,827 | 81.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 47 | 47 | $51,277 | $5,295 | 10.3% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 17 | 19 | $10,450 | $3,898 | 37.3% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 26 | 26 | $4,056 | $3,401 | 83.8% |
| 90670 | Pneumococcal vaccine, 13-valent | Office | 2023 | 16 | 16 | $3,200 | $3,136 | 98.0% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 15 | 331 | $9,599 | $2,863 | 29.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 36 | 36 | $9,616 | $2,759 | 28.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 36 | 38 | $36,594 | $2,702 | 7.4% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 16 | 17 | $6,630 | $2,558 | 38.6% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 14 | 14 | $13,132 | $2,468 | 18.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 44 | 47 | $8,730 | $2,048 | 23.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $6,885 | $1,814 | 26.3% |
| 85610 | Blood test, clotting time | Office | 2023 | 27 | 347 | $3,817 | $1,457 | 38.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 52 | 52 | $1,540 | $1,387 | 90.0% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 48 | 48 | $4,464 | $1,349 | 30.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 20 | 24 | $3,288 | $794.70 | 24.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 79 | 86 | $3,010 | $749.52 | 24.9% |
About Dr. Basil Pittenger, MD
Dr. Basil Pittenger, MD is a Internal Medicine healthcare provider based in Coos Bay, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1225013485.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Basil Pittenger, MD has received a total of $744.47 in payments from pharmaceutical and medical device companies, with $362.76 received in 2024. These payments were reported across 34 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($744.47).
As a Medicare-enrolled provider, Pittenger has provided services to 11,266 Medicare beneficiaries, totaling 24,720 services with total Medicare billing of $821,240. Data is available for 4 years (2020–2023), covering 176 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Coos Bay, OR
- Active Since 12/09/2005
- Last Updated 11/26/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1225013485
Products in Payments
- VersaCross Access Solution (Device) $112.02
- Repatha (Biological) $102.71
- ELIQUIS (Drug) $59.97
- XARELTO (Drug) $53.93
- Otezla (Drug) $49.87
- DEFINITY (Drug) $38.02
- REXULTI (Drug) $34.49
- JARDIANCE (Drug) $30.55
- UTIBRON (Drug) $27.68
- TRELEGY ELLIPTA (Drug) $23.99
- CAMZYOS (Drug) $21.77
- AIRSUPRA (Drug) $21.40
- SHINGRIX (Biological) $20.56
- VALTOCO (Drug) $18.78
- BROVANA (Drug) $18.59
- FARXIGA (Drug) $15.50
- CHANTIX (Drug) $15.43
- LONHALA MAGNAIR (Drug) $14.20
- INVOKANA (Drug) $13.85
- SUPREP (Drug) $13.61
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Coos Bay
Stacy Newman, Md, MD
Internal Medicine — Payments: $3,909
Internal Medicine $3,909
Carol Frank, Md, MD
Internal Medicine — Payments: $2,757
Internal Medicine $2,757
Dr. Joseph El Youssef, M.d, M.D
Internal Medicine — Payments: $1,892
Internal Medicine $1,892
Dr. Satish Bankuru, M.d, M.D
Internal Medicine — Payments: $1,739
Internal Medicine $1,739
Wendy Haack, D.o, D.O
Internal Medicine — Payments: $699.50
Internal Medicine $699.50
Bhavani Peddagovindu, Md, MD
Internal Medicine — Payments: $674.59
Internal Medicine $674.59